Anxiety Vulnerability and Smoking Cessation
焦虑脆弱性和戒烟
基本信息
- 批准号:7665597
- 负责人:
- 金额:$ 4.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAddressAffectAffectiveAnxietyAnxiety DisordersArtsAttentionBasic ScienceBehavioralCigarette SmokerClinicalCognitiveDependenceDevelopmentDiseaseEmotionsFrightFutureIndividual DifferencesInvestigationKnowledgeLeadLinkLiteratureMaintenanceMapsMediatingMethodologyModelingNational Institute of Mental HealthNicotine WithdrawalOutcomePanicPathway interactionsPersonsPharmaceutical PreparationsPlayPopulations at RiskPost-Traumatic Stress DisordersPrevalenceProcessPsyche structurePublic HealthRelapseReportingResearchResearch ProposalsRoleSmokeSmokerSmokingSmoking BehaviorSmoking Cessation InterventionSpecific qualifier valueTechnologyTestingTheoretical modelTimeTobacco useTranslatingWithdrawal SymptomWorkbasecigarette smokingclinically significantcopingdepressionexperienceindexinginnovationneglectprogramspublic health relevancesmoking cessationsuccess
项目摘要
DESCRIPTION (provided by applicant): The primary objectives of the current proposal are as follows: 1.a. To test the hypothesis that smokers characterized by higher compared to lower Anxiety Sensitivity (AS) will demonstrate less success in a self-guided cessation attempt, as indexed by: (1.a.1) Shorter time to first smoking lapse; (1.a.2) Lower point-prevalence abstinence at one, two, four, and 12 weeks post-quit date. 1.b. To test the hypothesis that the association between AS and lapse/relapse to smoking is mediated by the specified emotion and smoking-based processes, including: (1.b.1) Greater levels of negative affect intensity during the cessation attempt; (1.b.2) Greater levels of nicotine withdrawal symptom intensity during the cessation attempt. PUBLIC HEALTH RELEVANCE: The present proposal fills a needed clinically- and theoretically-relevant gap in the smoking- psychiatric literature, as recently espoused by the current NIMH smoking-psychiatric vulnerability report (Ziedonis et al., in press). Indeed, results of the proposed study will directly inform AS-smoking models, and serve more generally as an illustration of how specific anxiety-related processes serve to maintain smoking behavior. The proposed investigation represents a clinically significant and innovative test for a program of research aimed at understanding the mechanisms underlying smoking lapse and relapse.
描述(由申请人提供):当前提案的主要目标如下: 1.a.为了检验以下假设:与较低焦虑敏感性 (AS) 相比,吸烟者在自我引导戒烟尝试中表现出的成功率较低,其索引如下: (1.a.1) 首次戒烟时间较短; (1.a.2) 戒烟后 1、2、4 和 12 周的戒烟流行率较低。 1.b.检验 AS 与戒烟/复吸之间的关联是由特定情绪和基于吸烟的过程介导的假设,包括: (1.b.1) 尝试戒烟期间负面情绪强度更高; (1.b.2) 尝试戒烟期间尼古丁戒断症状强度更高。公共健康相关性:本提案填补了吸烟精神病学文献中所需的临床和理论相关空白,正如最新的 NIMH 吸烟精神病学脆弱性报告(Ziedonis 等人,出版中)所支持的那样。事实上,这项研究的结果将直接为 AS 吸烟模型提供信息,并更广泛地说明特定的焦虑相关过程如何维持吸烟行为。拟议的调查代表了一项具有临床意义和创新性的测试,旨在了解戒烟和复吸的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kirsten Johnson Langdon其他文献
Kirsten Johnson Langdon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kirsten Johnson Langdon', 18)}}的其他基金
Improving social connectedness through digital health to enhance recovery from OUD among the justice involved population.
通过数字健康改善社会联系,以促进司法相关人群从 OUD 中恢复。
- 批准号:
10675916 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别:
Integrating Long-Acting Injectable Treatment to Improve Medication Adherence among Persons Living with HIV and Opioid Use Disorder
整合长效注射治疗以提高艾滋病毒感染者和阿片类药物使用障碍患者的用药依从性
- 批准号:
10592361 - 财政年份:2022
- 资助金额:
$ 4.12万 - 项目类别:
Integrating Long-Acting Injectable Treatment to Improve Medication Adherence among Persons Living with HIV and Opioid Use Disorder
整合长效注射治疗以提高艾滋病毒感染者和阿片类药物使用障碍患者的用药依从性
- 批准号:
10401582 - 财政年份:2022
- 资助金额:
$ 4.12万 - 项目类别:
Integrated Digital Health Intervention to Promote Engagement in and Adherence to Medication-Assisted Treatment
综合数字健康干预促进药物辅助治疗的参与和坚持
- 批准号:
10382299 - 财政年份:2019
- 资助金额:
$ 4.12万 - 项目类别:
Integrated Digital Health Intervention to Promote Engagement in and Adherence to Medication-Assisted Treatment
综合数字健康干预促进药物辅助治疗的参与和坚持
- 批准号:
9923613 - 财政年份:2019
- 资助金额:
$ 4.12万 - 项目类别:
Integrated Digital Health Intervention to Promote Engagement in and Adherence to Medication-Assisted Treatment
综合数字健康干预促进药物辅助治疗的参与和坚持
- 批准号:
10608049 - 财政年份:2019
- 资助金额:
$ 4.12万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别:
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
- 批准号:
10701309 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别:
Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
- 批准号:
10546293 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别:
Circuit control of motivation to take and seek alcohol
饮酒和寻求酒精动机的电路控制
- 批准号:
10753712 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别:
The impact of early life opioid exposure on the molecular and functional trajectories of septal cell types
生命早期阿片类药物暴露对隔膜细胞类型分子和功能轨迹的影响
- 批准号:
10775154 - 财政年份:2023
- 资助金额:
$ 4.12万 - 项目类别: